Ignite Creation Date:
2024-05-06 @ 3:54 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04791384
Status:
RECRUITING
Last Update Posted:
2023-07-27
First Post:
2020-12-30
Brief Title:
Phase IbII Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HRHer2- Breast Cancer
Sponsor:
Criterium Inc
Organization:
Criterium Inc
Organization Data
Organization:
Criterium Inc
Class:
INDUSTRY
Study ID:
Lilly-I3Y-US-I026
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Criterium Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None